There is an entire mechanism for this, from consenting individuals in early stage trials to accelerated approvals. If you're curious, checkout the FDA's program

There is an entire mechanism for this, from consenting individuals in early stage trials to accelerated approvals. If you're curious, checkout the FDA's programs (http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm http://www.fda.gov/forconsumers/byaudience/forpatientadvocat...). This isn't everything, but it represents the interest of most players in getting these medications to patients as quickly as possible.